476 results on '"Waked, Imam"'
Search Results
2. Obesity prevalence in adults and patients with hepatitis C: results from screening a population of 50 million in Egypt
3. Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
4. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
5. Lymphoepithelioma-like Hepatocellular Carcinoma: a Case Report and Review of Literature
6. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
7. A global research priority agenda to advance public health responses to fatty liver disease
8. Evolution of liver fibrosis after interferon-based anti-hepatitis C virus therapy failure in 3,049 chronic hepatitis C patients without cirrhosis
9. Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt
10. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
11. Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study
12. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
13. Hepatitis C Elimination in Egypt: Story of Success.
14. Clinical Epidemiology of Hepatitis C Virus
15. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
16. Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.
17. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
18. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
19. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]
20. Joint statement in support of hepatitis C human challenge studies
21. High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C
22. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
23. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era
24. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians
25. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region
26. Efficacy and safety of Sofosbuvir Plus Daclatasvir bilayer tablet with or without Ribavirin in patients with chronic hepatitis C genotype 4 Infection
27. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C
28. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & HepatologyCommission update
29. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
30. Paracentesis-induced circulatory dysfunction: are there albumin alternatives?
31. High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction
32. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians
33. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial
34. Joint statement in support of hepatitis C human challenge studies
35. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment
36. Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum
37. Clinical Epidemiology of Hepatitis C Virus
38. Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.
39. Hepatitis delta virus infection in the Middle East
40. Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study
41. The current and future disease burden of chronic hepatitis C virus infection in Egypt
42. Female Sexual Dysfunction Among Egyptian Patients with Chronic Hepatitis C
43. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease
44. Introductory Chapter: Updates on the Management of Hepatocellular Carcinoma
45. Introductory Chapter: Treatment of Viral Hepatitis - Current Challenges and Future Perspectives
46. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality
47. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model.
48. Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies
49. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients
50. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020:a modelling study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.